Skip to content

Behrooz A. Torkian, MD

NPI 1659497824ActiveIndividual· Otolaryngology, Facial Plastic Surgery· Los Angeles, CA

Otolaryngology, Facial Plastic Surgery (MD) in Los Angeles, California, licensed in CA, with an NPI issued in March 2007. Part D covered 36 prescriptions written in 2024, 97% of them generic. Revance Therapeutics, Inc. was the largest of 5 companies reporting payments in 2025, $1,449 in all, mostly food and beverage.

Overview

NPI1659497824
StatusActive
Entity typeIndividual
CredentialMD
Sole proprietorYes
NPI issuedMar 21, 2007
Last updated in NPPESJul 8, 2007

Specialties and licenses

TaxonomyCodeLicenseState
Otolaryngology, Facial Plastic Surgery Primary207YS0123XA78758CA

About license numbers in NPPES

Exclusion screening

ListResultDetails
HHS-OIG LEIE · Oct 9, 2026No matchChecked by NPI and by name + state
North Carolina Medicaid · Nov 10, 2026No match—
New York OMIG · Nov 10, 2026No match—
Ohio Medicaid · Nov 10, 2026No match—
Pennsylvania Medicheck · Nov 10, 2026No match—
Washington HCA · Nov 10, 2026No match—

Official OIG search · How matching works ·Bulk check a roster

Medicare

Enrollment (PECOS)Not in the public enrollment file of Oct 1, 2026

Part D prescriptions in 2024

Prescriptions (claims)36 · 40 30-day fills
Patients15
Total drug cost$243.10
Generic share97% of claims

Medicare sources and data years

Industry payments (Open Payments)

  • 2025$1,449 · 42 payments from 5 companies
  • 2024$5,770 · 64 payments from 4 companies

Top paying companies in 2025

What the 2025 payments were for

  • Food and Beverage$1,449 · 42 payments

Receiving payments does not imply wrongdoing. What Open Payments covers ·original records

Other Otolaryngology, Facial Plastic Surgery providers in Los Angeles

All Otolaryngology, Facial Plastic Surgery providers in California →